首页> 外国专利> COMPOSITIONS INHIBITING AND FIGHTING AGAINST THE ANGIOGENESIS AS WELL AS CAUSING ITS REGRESSION, CONTAINING HIALURONIC ACID NON-STERIDE ANTI-INFLAMMATORY AGENT

COMPOSITIONS INHIBITING AND FIGHTING AGAINST THE ANGIOGENESIS AS WELL AS CAUSING ITS REGRESSION, CONTAINING HIALURONIC ACID NON-STERIDE ANTI-INFLAMMATORY AGENT

机译:含有抗血管生成作用的成分,以及引起其退变的成分,其中包含不具透明质酸的羟醛酸抗炎剂

摘要

The use of: (a) a non-steroidal anti-inflammatory agent, and (b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of hyaluronic acid, in the manufacture of a pharmaceutical composition for inhibiting, controlling and/or regressing angiogenesis in a therapy wherein dosage amounts taken from the composition each comprise: (1) a therapeutically effective amount of component (a); and (2) a therapeutically effective amount of the hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and sub-units of hyaluronic acid, the pharmaceutical composition being characterized in that for each dosage amount taken from the pharmaceutical composition, the amount of components (a) and (b) inhibit, control and/or regress angiogenesis.
机译:(a)非甾体抗炎药,和(b)透明质酸和/或其盐和/或透明质酸的同系物,类似物,衍生物,复合物,酯,片段和亚基的用途。制造用于在治疗中抑制,控制和/或消退血管生成的药物组合物,其中从该组合物中获取的剂量各自包括:(1)治疗有效量的组分(a); (2)透明质酸和/或其盐和/或透明质酸的同系物,类似物,衍生物,复合物,酯,片段和亚基的治疗有效量,所述药物组合物的特征在于对于每种剂量选自药物组合物的量,组分(a)和(b)的量抑制,控制和/或消退血管生成。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号